Your browser doesn't support javascript.
loading
[Comparative study of molecular response of first-line and second-line nilotinib in patients with chronic-phase chronic myelogenous leukemia].
Xu, H; Wang, P; Ma, R J; Guo, J M; Lei, P C; Zang, Y Z; Wang, T B; Liu, Z W; Yang, J; Zhang, Y; Zhu, Z M.
Afiliación
  • Xu H; Jinzhou Medical University, Jinzhou 121001, China; Hematology of Department, Henan Province People's Hospital, Zhengzhou 450003, China.
  • Wang P; Hematology of Department, Xinyang Central Hospital, Xinyang 464000, China.
  • Ma RJ; Hematology of Department, Henan Province People's Hospital, Zhengzhou 450003, China.
  • Guo JM; Hematology of Department, Henan Province People's Hospital, Zhengzhou 450003, China.
  • Lei PC; Hematology of Department, Henan Province People's Hospital, Zhengzhou 450003, China.
  • Zang YZ; Hematology of Department, Henan Province People's Hospital, Zhengzhou 450003, China.
  • Wang TB; Hematology of Department, Henan Province People's Hospital, Zhengzhou 450003, China.
  • Liu ZW; Hematology of Department, Henan Province People's Hospital, Zhengzhou 450003, China.
  • Yang J; Hematology of Department, Henan Province People's Hospital, Zhengzhou 450003, China.
  • Zhang Y; Hematology of Department, Henan Province People's Hospital, Zhengzhou 450003, China.
  • Zhu ZM; Hematology of Department, Henan Province People's Hospital, Zhengzhou 450003, China; Institute of Hematology, Henan Province People's Hospital, Zhengzhou 450003, China.
Zhonghua Xue Ye Xue Za Zhi ; 40(6): 522-525, 2019 06 14.
Article en Zh | MEDLINE | ID: mdl-31340628

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Leucemia Mieloide de Fase Crónica Límite: Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Leucemia Mieloide de Fase Crónica Límite: Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2019 Tipo del documento: Article País de afiliación: China